Sandostatin Injection, Solution
Product Images NDC 0078-0181

4 FDA label images from Novartis Pharmaceuticals Corporation · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sandostatin (NDC 0078-0181). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sandostatin 01

Sandostatin 01
Packaging label for Sandostatin octreotide acetate injection, 50 mcg/mL, presented as an ampul unit dose package. The label indicates it is for subcutaneous or intravenous use, contains 10 ampuls of 1 mL each, and is distributed by Novartis Pharmaceuticals Corporation. Storage and usage instructions are included on the label.*
FDA Label Image

Octreotide Acetate Amino Acid Sequence (Sandostatin 02)

Octreotide Acetate Amino Acid Sequence (Sandostatin 02)
Chemical structure of octreotide acetate showing its peptide chain with labeled amino acids and the variable segment where x equals 1.4 to 2.5.*
FDA Label Image

Principal Display Panelpackage Label – 50 Mcg/mlrx Only Ndc 0078 0180 01sandostatin Injection Octreotide Acetate50 Mcg/ml (0.05 mg/ml) (Sandostatin 03)

Principal Display Panelpackage Label – 50 Mcg/mlrx Only		Ndc 0078 0180 01sandostatin Injection Octreotide Acetate50 Mcg/ml (0.05 mg/ml) (Sandostatin 03)
Sandostatin 500 mcg/mL octreotide acetate injection solution packaging label. The product is for subcutaneous or intravenous use and comes in a box containing 10 ampuls of 1 mL each. The label includes dosage strength, usage instructions, storage information, and manufacturer details: Novartis Pharmaceuticals Corporation.*
FDA Label Image

Principal Display Panelpackage Label – 100 Mcg/mlrx Only Ndc 0078 0181 01sandostatin Injectionoctreotide Acetate100 Mcg/ml (0.1 mg/ml) (Sandostatin 04)

Principal Display Panelpackage Label – 100 Mcg/mlrx Only		Ndc 0078 0181 01sandostatin Injectionoctreotide Acetate100 Mcg/ml (0.1 mg/ml) (Sandostatin 04)
Packaging label for Sandostatin (octreotide acetate) injection, 100 mcg/mL strength. The label indicates it is for subcutaneous or intravenous use and comes in a unit dose package containing 10 ampuls of 1 mL each. The labeler is Novartis Pharmaceuticals Corporation. The label includes storage instructions, inactive ingredients, and illustrations showing how to open the ampul.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.